Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Harmonization Hurdles On Horizon, CDRH Director Feigal Tells RAPS

This article was originally published in The Gray Sheet

Executive Summary

Global harmonization efforts are making device product launches in different countries more difficult in the short term, according to CDRH Director David Feigal

You may also be interested in...



IVD Manufacturers Are Introduced To STED Format; Future Eligibility Pending

CDRH is reaching out to in vitro diagnostic manufacturers to familiarize them with the "Summary Technical Documentation for Demonstrating Conformity" (STED) initiative, though IVDs currently are ineligible for the pilot program

IVD Manufacturers Are Introduced To STED Format; Future Eligibility Pending

CDRH is reaching out to in vitro diagnostic manufacturers to familiarize them with the "Summary Technical Documentation for Demonstrating Conformity" (STED) initiative, though IVDs currently are ineligible for the pilot program

New Japanese Agency Will Accept STED; MHLW Retains Payment Control

Japan's Ministry of Health, Labor & Welfare will accept medical device applications in the STED format beginning next April, according to the U.S. Trade Representative's "1Third Report To The Leaders On The U.S.-Japan Regulatory Reform And Competition Policy Initiative," released June 8

Related Content

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel